PACIRA BIOSCIENCES, INC. Increase (Decrease) in Other Operating Liabilities
PACIRA BIOSCIENCES, INC. (PCRX) reported Increase (Decrease) in Other Operating Liabilities of $4.36 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-08-04
- PACIRA BIOSCIENCES, INC. increase (decrease) in other operating liabilities for the quarter ending 2026-06-30 was $1.07M, a 89.10% decline year-over-year.
- PACIRA BIOSCIENCES, INC. increase (decrease) in other operating liabilities for the quarter ending 2026-03-31 was $3.29M, a 203.88% increase year-over-year.
- PACIRA BIOSCIENCES, INC. increase (decrease) in other operating liabilities for the quarter ending 2025-09-30 was -$5.83M.
- PACIRA BIOSCIENCES, INC. increase (decrease) in other operating liabilities for the quarter ending 2025-06-30 was $9.82M.
- PACIRA BIOSCIENCES, INC. increase (decrease) in other operating liabilities for fiscal 2024 was $2.71M, a 525.35% increase from fiscal 2023.
- PACIRA BIOSCIENCES, INC. increase (decrease) in other operating liabilities for fiscal 2023 was $434.00K.
- PACIRA BIOSCIENCES, INC. increase (decrease) in other operating liabilities for fiscal 2022 was -$556.00K.
- PACIRA BIOSCIENCES, INC. increase (decrease) in other operating liabilities for fiscal 2021 was -$104.00K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 3 month as first filed | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 6 month as first filed | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 9 month as first filed | Increase (Decrease) in Other Operating Liabilities 12 month | Increase (Decrease) in Other Operating Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $4.36M 10-Q · filed 2026-08-04 | ||||||
| 2026-03-31 | $3.29M 10-Q · filed 2026-04-30 | |||||||
| 2025-09-30 | -$5.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $4.00M derived: sum of 2 quarters · filed 2026-08-04 | $5.08M 10-Q · filed 2025-11-06 | $8.99M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $9.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $10.90M 10-Q · filed 2026-08-04 | $14.81M derived: sum of 3 quarters · filed 2026-08-04 | $14.41M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $1.08M 10-Q · filed 2026-04-30 | $4.99M derived: sum of 2 quarters · filed 2026-04-30 | $4.59M derived: sum of 3 quarters · filed 2026-04-30 | $4.57M derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | $3.91M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $3.50M derived: sum of 2 quarters · filed 2025-11-06 | $3.48M derived: sum of 3 quarters · filed 2025-11-06 | $2.71M 10-K · filed 2025-02-27 | ||||
| 2024-09-30 | -$405.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$424.00K derived: sum of 2 quarters · filed 2025-11-06 | -$1.20M 10-Q · filed 2025-11-06 | -$801.00K derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | -$19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$790.00K 10-Q · filed 2025-08-05 | -$396.00K derived: sum of 3 quarters · filed 2025-08-05 | -$634.00K derived: sum of 4 quarters · filed 2025-08-05 | ||||
| 2024-03-31 | -$771.00K 10-Q · filed 2025-05-08 | -$377.00K derived: sum of 2 quarters · filed 2025-05-08 | -$615.00K derived: sum of 3 quarters · filed 2025-05-08 | -$758.00K derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | $394.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $156.00K derived: sum of 2 quarters · filed 2025-02-27 | $13.00K derived: sum of 3 quarters · filed 2025-02-27 | $434.00K 10-K · filed 2025-02-27 | ||||
| 2023-09-30 | -$238.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$381.00K derived: sum of 2 quarters · filed 2024-11-06 | $40.00K 10-Q · filed 2024-11-06 | -$1.14M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-06-30 | -$143.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $278.00K 10-Q · filed 2024-07-30 | -$901.00K derived: sum of 3 quarters · filed 2025-02-27 | -$757.00K derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-03-31 | $421.00K 10-Q · filed 2024-05-07 | -$758.00K derived: sum of 2 quarters · filed 2025-02-27 | -$614.00K derived: sum of 3 quarters · filed 2025-02-27 | |||||
| 2022-12-31 | -$1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$1.03M derived: sum of 2 quarters · filed 2025-02-27 | -$556.00K 10-K · filed 2025-02-27 | |||||
| 2022-09-30 | $144.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $623.00K 10-Q · filed 2023-11-02 | ||||||
| 2022-06-30 | $479.00K 10-Q · filed 2023-08-02 | |||||||
| 2021-12-31 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $860.00K derived: sum of 2 quarters · filed 2024-02-29 | $1.60M derived: sum of 3 quarters · filed 2024-02-29 | -$104.00K 10-K · filed 2024-02-29 | -$229.00K 10-K · filed 2022-02-28 | |||
| 2021-09-30 | -$1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$295.00K derived: sum of 2 quarters · filed 2021-11-03 | -$2.00M 10-Q · filed 2021-11-03 | -$2.79M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | $737.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$964.00K 10-Q · filed 2021-08-03 | -$1.76M derived: sum of 3 quarters · filed 2023-02-28 | -$379.00K derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | -$1.70M 10-Q · filed 2021-05-04 | -$2.50M derived: sum of 2 quarters · filed 2023-02-28 | -$1.12M derived: sum of 3 quarters · filed 2023-02-28 | -$3.00M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | -$797.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $585.00K derived: sum of 2 quarters · filed 2023-02-28 | -$1.29M derived: sum of 3 quarters · filed 2023-02-28 | -$2.47M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $1.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$497.00K derived: sum of 2 quarters · filed 2021-11-03 | -$1.67M 10-Q · filed 2021-11-03 | -$7.57M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-06-30 | -$1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$3.05M 10-Q · filed 2021-08-03 | -$8.96M derived: sum of 3 quarters · filed 2022-02-28 | -$9.53M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-03-31 | -$1.17M 10-Q · filed 2021-05-04 | -$7.08M derived: sum of 2 quarters · filed 2022-02-28 | -$7.65M derived: sum of 3 quarters · filed 2022-02-28 | -$7.85M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2019-12-31 | -$5.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$6.48M derived: sum of 2 quarters · filed 2022-02-28 | -$6.67M derived: sum of 3 quarters · filed 2022-02-28 | -$6.73M 10-K · filed 2022-02-28 | ||||
| 2019-09-30 | -$577.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | -$771.00K derived: sum of 2 quarters · filed 2020-10-30 | -$822.00K 10-Q · filed 2020-10-30 | -$737.00K derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-30 | -$194.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$245.00K 10-Q · filed 2020-08-06 | -$160.00K derived: sum of 3 quarters · filed 2021-03-01 | $327.00K derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-31 | -$51.00K 10-Q · filed 2020-05-07 | $34.00K derived: sum of 2 quarters · filed 2021-03-01 | $521.00K derived: sum of 3 quarters · filed 2021-03-01 | $955.00K derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | $85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $572.00K derived: sum of 2 quarters · filed 2021-03-01 | $1.01M derived: sum of 3 quarters · filed 2021-03-01 | $897.00K 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | $487.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $921.00K derived: sum of 2 quarters · filed 2019-11-08 | $812.00K 10-Q · filed 2019-11-08 | $256.00K derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2018-06-30 | $434.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $325.00K 10-Q · filed 2019-08-08 | -$231.00K derived: sum of 3 quarters · filed 2020-02-21 | -$1.75M derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2018-03-31 | -$109.00K 10-Q · filed 2019-05-02 | -$665.00K derived: sum of 2 quarters · filed 2020-02-21 | -$2.18M derived: sum of 3 quarters · filed 2020-02-21 | -$2.40M derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2017-12-31 | -$556.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | -$2.08M derived: sum of 2 quarters · filed 2020-02-21 | -$2.29M derived: sum of 3 quarters · filed 2020-02-21 | -$3.56M 10-K · filed 2020-02-21 | ||||
| 2017-09-30 | -$1.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$1.73M derived: sum of 2 quarters · filed 2018-11-01 | -$3.00M 10-Q · filed 2018-11-01 | -$4.45M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-06-30 | -$214.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$1.48M 10-Q · filed 2018-08-02 | -$2.93M derived: sum of 3 quarters · filed 2019-02-28 | -$4.86M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-03-31 | -$1.27M 10-Q · filed 2018-05-03 | -$1.06M 10-Q · filed 2017-05-04 | -$2.72M derived: sum of 2 quarters · filed 2019-02-28 | -$4.65M derived: sum of 3 quarters · filed 2019-02-28 | -$2.19M derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2016-12-31 | -$1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$3.38M derived: sum of 2 quarters · filed 2019-02-28 | -$920.00K derived: sum of 3 quarters · filed 2019-02-28 | -$1.34M 10-K · filed 2019-02-28 | $87.00K 10-K · filed 2017-03-01 | |||
| 2016-09-30 | -$1.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $534.00K derived: sum of 2 quarters · filed 2017-11-08 | $115.00K 10-Q · filed 2017-11-08 | $1.18M 10-Q · filed 2016-11-02 | $3.48M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2016-06-30 | $2.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $2.04M 10-Q · filed 2017-08-02 | $2.76M 10-Q · filed 2016-08-04 | $5.42M derived: sum of 3 quarters · filed 2018-02-28 | $6.37M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2016-03-31 | -$419.00K 10-Q · filed 2017-05-04 | $2.95M derived: sum of 2 quarters · filed 2018-02-28 | $3.90M derived: sum of 3 quarters · filed 2018-02-28 | $3.91M derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2015-12-31 | $3.37M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $4.32M derived: sum of 2 quarters · filed 2018-02-28 | $4.33M derived: sum of 3 quarters · filed 2018-02-28 | $4.36M 10-K · filed 2018-02-28 | $5.79M 10-K · filed 2016-02-25 | |||
| 2015-09-30 | $952.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $961.00K derived: sum of 2 quarters · filed 2016-11-02 | $990.00K 10-Q · filed 2016-11-02 | $3.52M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $38.00K 10-Q · filed 2016-08-04 | $2.56M derived: sum of 3 quarters · filed 2017-03-01 | $3.44M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | $29.00K 10-Q · filed 2016-05-02 | $2.56M derived: sum of 2 quarters · filed 2017-03-01 | $3.43M derived: sum of 3 quarters · filed 2017-03-01 | $4.42M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | $2.53M 10-K · filed 2017-03-01 | $3.40M derived: sum of 2 quarters · filed 2017-03-01 | $4.39M derived: sum of 3 quarters · filed 2017-03-01 | $2.53M 10-K · filed 2016-02-25 | $2.35M 10-K · filed 2015-02-24 | |||
| 2014-09-30 | $879.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27 | $1.86M derived: sum of 2 quarters · filed 2015-10-27 | $2.14M 10-Q · filed 2015-10-27 | $2.45M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-06-30 | $985.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $1.26M 10-Q · filed 2015-07-30 | $1.57M derived: sum of 3 quarters · filed 2016-02-25 | $1.78M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-03-31 | $278.00K 10-Q · filed 2015-04-30 | $590.00K derived: sum of 2 quarters · filed 2016-02-25 | $793.00K derived: sum of 3 quarters · filed 2016-02-25 | $875.00K derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2013-12-31 | $312.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $515.00K derived: sum of 2 quarters · filed 2016-02-25 | $597.00K derived: sum of 3 quarters · filed 2016-02-25 | $1.05M 10-K · filed 2016-02-25 | ||||
| 2013-09-30 | $203.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $285.00K derived: sum of 2 quarters · filed 2014-10-30 | $735.00K 10-Q · filed 2014-10-30 | $712.00K derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-06-30 | $82.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $532.00K 10-Q · filed 2014-07-31 | $509.00K derived: sum of 3 quarters · filed 2015-02-24 | $468.00K derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-03-31 | $450.00K 10-Q · filed 2014-05-01 | $427.00K derived: sum of 2 quarters · filed 2015-02-24 | $386.00K derived: sum of 3 quarters · filed 2015-02-24 | $347.00K derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2012-12-31 | -$23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$64.00K derived: sum of 2 quarters · filed 2015-02-24 | -$103.00K derived: sum of 3 quarters · filed 2015-02-24 | -$106.00K 10-K · filed 2015-02-24 | ||||
| 2012-09-30 | -$41.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | -$80.00K derived: sum of 2 quarters · filed 2013-10-31 | -$83.00K 10-Q · filed 2013-10-31 | -$778.00K derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | -$39.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | -$42.00K 10-Q · filed 2013-08-06 | -$737.00K derived: sum of 3 quarters · filed 2014-02-25 | -$711.00K derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | -$3.00K 10-Q · filed 2013-05-08 | -$698.00K derived: sum of 2 quarters · filed 2014-02-25 | -$672.00K derived: sum of 3 quarters · filed 2014-02-25 | -$644.00K derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | -$695.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | -$669.00K derived: sum of 2 quarters · filed 2014-02-25 | -$641.00K derived: sum of 3 quarters · filed 2014-02-25 | $27.00K 10-K · filed 2014-02-25 | ||||
| 2011-09-30 | $26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $54.00K derived: sum of 2 quarters · filed 2012-11-01 | $722.00K 10-Q · filed 2012-11-01 | $2.20M 10-Q · filed 2011-10-31 | $1.59M derived: sum of 4 quarters · filed 2013-03-07 | |||
| 2011-06-30 | $28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $696.00K 10-Q · filed 2012-08-09 | $792.00K 10-Q · filed 2011-08-11 | $1.57M derived: sum of 3 quarters · filed 2013-03-07 | $1.74M derived: sum of 4 quarters · filed 2013-03-07 | |||
| 2011-03-31 | $668.00K 10-Q · filed 2012-05-09 | $1.54M derived: sum of 2 quarters · filed 2013-03-07 | $1.71M derived: sum of 3 quarters · filed 2013-03-07 | |||||
| 2010-12-31 | $873.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | $1.04M derived: sum of 2 quarters · filed 2013-03-07 | $1.78M 10-K · filed 2013-03-07 | |||||
| 2010-09-30 | $169.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $909.00K 10-Q · filed 2011-10-31 | ||||||
| 2010-06-30 | $740.00K 10-Q · filed 2011-08-11 | |||||||
| 2009-12-31 | $3.03M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |